Similar response rates were observed for patients who were MTX-naïve and TNF-naïve and those who were csDMARD-naïve and TNF-naïve; however, these differences did not reach statistical significance ( figure 2A ).
← all excerpts
Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2.
1
—
—